Osteopore Ltd (OSX) - Cash Flow Conversion Efficiency

Latest as of June 2025: 3.011x

Based on the latest financial reports, Osteopore Ltd (OSX) has a cash flow conversion efficiency ratio of 3.011x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-1.28 Million ≈ $-902.50K USD) by net assets (AU$-423.65K ≈ $-299.76K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Osteopore Ltd - Cash Flow Conversion Efficiency Trend (2016–2024)

This chart illustrates how Osteopore Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Osteopore Ltd total liabilities for a breakdown of total debt and financial obligations.

Osteopore Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Osteopore Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Tristel
LSE:TSTL
0.161x
Foresight Autonomous Holdings Ltd
TA:FRSX
-0.464x
Enorama Pharma AB
ST:ERMA
0.631x
Mdundo Com As
CO:MDUNDO
-0.275x
Bone Biologics Corp
NASDAQ:BBLG
-0.098x
PBS Finanse SA
WAR:PBF
-0.096x
Olivut Resources Ltd
V:OLV
-0.350x
ModuLink Inc.
NASDAQ:MDLK
-2.896x

Annual Cash Flow Conversion Efficiency for Osteopore Ltd (2016–2024)

The table below shows the annual cash flow conversion efficiency of Osteopore Ltd from 2016 to 2024. For the full company profile with market capitalisation and key ratios, see Osteopore Ltd market capitalisation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 AU$306.22K
≈ $216.67K
AU$-3.09 Million
≈ $-2.18 Million
-10.084x -16.73%
2023-12-31 AU$432.60K
≈ $306.09K
AU$-3.74 Million
≈ $-2.64 Million
-8.639x -355.31%
2022-12-31 AU$2.11 Million
≈ $1.49 Million
AU$-4.00 Million
≈ $-2.83 Million
-1.897x -167.87%
2021-12-31 AU$5.37 Million
≈ $3.80 Million
AU$-3.81 Million
≈ $-2.69 Million
-0.708x -262.52%
2020-12-31 AU$9.00 Million
≈ $6.37 Million
AU$-1.76 Million
≈ $-1.24 Million
-0.195x +66.85%
2019-12-31 AU$2.97 Million
≈ $2.10 Million
AU$-1.75 Million
≈ $-1.24 Million
-0.589x -646.63%
2018-12-31 AU$4.23 Million
≈ $3.00 Million
AU$-334.12K
≈ $-236.41K
-0.079x -1197.74%
2017-12-31 AU$-1.84 Million
≈ $-1.30 Million
AU$11.16K
≈ $7.90K
-0.006x -104.48%
2016-12-31 AU$-1.36 Million
≈ $-959.71K
AU$-184.27K
≈ $-130.38K
0.136x --

About Osteopore Ltd

AU:OSX Australia Medical Instruments & Supplies
Market Cap
$2.39 Million
AU$3.38 Million AUD
Market Cap Rank
#29499 Global
#1737 in Australia
Share Price
AU$0.01
Change (1 day)
+16.67%
52-Week Range
AU$0.01 - AU$0.03
All Time High
AU$15.65
About

Osteopore Limited, a regenerative medicine company, engages in the production of 3D-printed biomimetic and bioresorbable implants in Vietnam, South Korea, the Philippines, Singapore, India, Malaysia, the Netherlands, Thailand, Australia, and internationally. The company commercializes products designed to enable natural bone healing across multiple therapeutic areas. Its technology fabricates spe… Read more